Hung‐Cheng Lai

5.4k total citations · 1 hit paper
88 papers, 4.2k citations indexed

About

Hung‐Cheng Lai is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Hung‐Cheng Lai has authored 88 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 26 papers in Cancer Research and 23 papers in Epidemiology. Recurrent topics in Hung‐Cheng Lai's work include Epigenetics and DNA Methylation (35 papers), Cervical Cancer and HPV Research (20 papers) and Cancer-related molecular mechanisms research (16 papers). Hung‐Cheng Lai is often cited by papers focused on Epigenetics and DNA Methylation (35 papers), Cervical Cancer and HPV Research (20 papers) and Cancer-related molecular mechanisms research (16 papers). Hung‐Cheng Lai collaborates with scholars based in Taiwan, United States and China. Hung‐Cheng Lai's co-authors include Kenneth P. Nephew, Pearlly S. Yan, Tim H-M. Huang, Michael W.Y. Chan, Curt Balch, Rui Huang, Shu Zhang, Daniela Matei, Jeanne M. Schilder and Tang‐Yuan Chu and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer Research.

In The Last Decade

Hung‐Cheng Lai

86 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors

2008 1.1k citations Shu Zhang, Curt Balch et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hung‐Cheng Lai Taiwan	37	2.7k	1.4k	1.2k	761	427	88	4.2k
Paul Haluska United States	38	2.5k 0.9×	2.0k 1.4×	1.1k 0.9×	376 0.5×	411 1.0×	114	4.9k
Karin Milde‐Langosch Germany	42	3.2k 1.2×	1.9k 1.3×	1.8k 1.4×	563 0.7×	429 1.0×	130	5.6k
Katsutoshi Oda Japan	35	2.6k 0.9×	1.6k 1.1×	786 0.6×	568 0.7×	973 2.3×	195	4.9k
Hugo Arias‐Pulido United States	30	1.6k 0.6×	778 0.5×	637 0.5×	632 0.8×	167 0.4×	59	2.9k
Ate G.J. van der Zee Netherlands	35	1.5k 0.6×	1.0k 0.7×	738 0.6×	510 0.7×	943 2.2×	63	3.8k
Rebecca T. Marquez United States	24	1.8k 0.7×	481 0.3×	867 0.7×	417 0.5×	564 1.3×	32	3.1k
P Speiser Austria	31	1.3k 0.5×	925 0.6×	777 0.6×	287 0.4×	602 1.4×	163	3.0k
Burkhard Helmke Germany	28	1.3k 0.5×	897 0.6×	484 0.4×	185 0.2×	330 0.8×	78	2.9k
Cécile Le Page Canada	28	1.2k 0.5×	1.1k 0.8×	567 0.5×	265 0.3×	355 0.8×	62	3.1k
Paulette Mhawech‐Fauceglia United States	35	1.9k 0.7×	2.0k 1.4×	689 0.6×	273 0.4×	651 1.5×	126	5.0k

Countries citing papers authored by Hung‐Cheng Lai

Since Specialization

Citations

This map shows the geographic impact of Hung‐Cheng Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hung‐Cheng Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hung‐Cheng Lai more than expected).

Fields of papers citing papers by Hung‐Cheng Lai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hung‐Cheng Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hung‐Cheng Lai. The network helps show where Hung‐Cheng Lai may publish in the future.

Co-authorship network of co-authors of Hung‐Cheng Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Hung‐Cheng Lai. A scholar is included among the top collaborators of Hung‐Cheng Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hung‐Cheng Lai. Hung‐Cheng Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Lin‐Yu, Yu‐Ting Chou, Phui‐Ly Liew, et al.. (2024). In vitro drug testing using patient-derived ovarian cancer organoids. Journal of Ovarian Research. 17(1). 194–194. 2 indexed citations

Lai, Hung‐Cheng, Chen Shu, Xiaofeng Luo, et al.. (2024). PRODH Regulates Tamoxifen Resistance through Ferroptosis in Breast Cancer Cells. Genes. 15(10). 1316–1316.

Chen, Lin‐Yu, Shuyi Yang, Jian‐Liang Chou, et al.. (2024). The Role of SMAD7 in the Epigenetic Regulation of TGF‐β Targets in the Metastasis of Ovarian Cancer. Molecular Carcinogenesis. 64(2). 290–304.

Shinjo, Keiko, Keisuke Katsushima, Atsushi Arakawa, et al.. (2019). ZNF671 DNA methylation as a molecular predictor for the early recurrence of serous ovarian cancer. Cancer Science. 110(3). 1105–1116. 30 indexed citations

Huang, Rui, Phui‐Ly Liew, Po‐Hsuan Su, et al.. (2018). GATA3 as a master regulator and therapeutic target in ovarian high‐grade serous carcinoma stem cells. International Journal of Cancer. 143(12). 3106–3119. 32 indexed citations

Chang, Cheng‐Chang, Hui-Chen Wang, Yu-Ping Liao, et al.. (2017). The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings. Journal of Gynecologic Oncology. 29(1). e17–e17. 39 indexed citations

Chung, Vin Yee, et al.. (2017). Loss of discoidin domain receptor 1 (DDR1) via CpG methylation during EMT in epithelial ovarian cancer. Gene. 635. 9–15. 18 indexed citations

Huang, Rui, Po‐Hsuan Su, Yu-Ping Liao, et al.. (2016). Integrated Epigenomics Analysis Reveals a DNA Methylation Panel for Endometrial Cancer Detection Using Cervical Scrapings. Clinical Cancer Research. 23(1). 263–272. 65 indexed citations

Chen, Tze-Chien, Huei‐Jean Huang, Tao-Yeuan Wang, et al.. (2015). Primary surgery versus primary radiation therapy for FIGO stages I–II small cell carcinoma of the uterine cervix: A retrospective Taiwanese Gynecologic Oncology Group study. Gynecologic Oncology. 137(3). 468–473. 49 indexed citations

10.

Lai, Hung‐Cheng, Yu-Chi Wang, Mu‐Hsien Yu, et al.. (2014). DNA methylation as a biomarker for the detection of hidden carcinoma in endometrial atypical hyperplasia. Gynecologic Oncology. 135(3). 552–559. 31 indexed citations

11.

Hsu, Ya‐Ting, Fei Gu, Yi-Wen Huang, et al.. (2013). Promoter Hypomethylation of EpCAM-Regulated Bone Morphogenetic Protein Gene Family in Recurrent Endometrial Cancer. Clinical Cancer Research. 19(22). 6272–6285. 36 indexed citations

12.

Huang, Hsin-Hui, et al.. (2013). Robot-assisted excision of a symptomatic deep infiltrating cervical endometrioma. Taiwanese Journal of Obstetrics and Gynecology. 52(3). 437–439. 1 indexed citations

13.

Lin, Yi-Hsin, Rui Huang, & Hung‐Cheng Lai. (2011). Presacral teratoma in a Curarrino syndrome woman with an unreported insertion in MNX1 gene. Taiwanese Journal of Obstetrics and Gynecology. 50(4). 512–514. 8 indexed citations

14.

Su, Her‐Young, Hung‐Cheng Lai, Ya‐Wen Lin, et al.. (2009). Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway. International Journal of Cancer. 127(3). 555–567. 154 indexed citations

15.

Zhang, Shu, Curt Balch, Michael W.Y. Chan, et al.. (2008). Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors. Cancer Research. 68(11). 4311–4320. 1055 indexed citations breakdown →

16.

Lai, Hung‐Cheng, Hsin‐Yi Lee, Wei‐Hsin Lin, et al.. (2008). Valproic acid resensitizes cisplatin‐resistant ovarian cancer cells. Cancer Science. 99(6). 1218–1226. 58 indexed citations

17.

Lai, Hung‐Cheng, Ya‐Wen Lin, Cheng‐Chang Chang, et al.. (2006). Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias. Gynecologic Oncology. 104(3). 629–635. 41 indexed citations

18.

Nieh, Shin, et al.. (2005). Is p16INK4A expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies. Gynecologic Oncology. 97(1). 35–40. 67 indexed citations

19.

Nieh, Shin, et al.. (2004). Expression of p16INK4A in Pap Smears Containing Atypical Glandular Cells from the Uterine Cervix. Acta Cytologica. 48(2). 173–180. 21 indexed citations

20.

Lai, Hung‐Cheng, Chi‐Ming Chu, Ya‐Wen Lin, et al.. (2004). Matrix metalloproteinase 1 gene polymorphism as a prognostic predictor of invasive cervical cancer. Gynecologic Oncology. 96(2). 314–319. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact